Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02486536
Other study ID # 2015-045k
Secondary ID
Status Completed
Phase Phase 4
First received June 24, 2015
Last updated June 20, 2017
Start date July 2015
Est. completion date June 2017

Study information

Verified date June 2017
Source Shanghai Jiao Tong University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the ideal dose of PEG and timing of bowel preparation in patients referred for CE examination.


Recruitment information / eligibility

Status Completed
Enrollment 410
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients aged between 18 and 75 years and referred to capsule endoscopy because of suspected small-bowel disease are prospectively eligible for entry into the study.

Exclusion Criteria:

- Age < 18 or > 75 years

- Known or suspected GI stricture or fistula

- A history of GI tract resection

- Swallowing disorders

- Intensive therapy with fasting and parenteral nutrition;with a disease that may reduce movement of the GI tract, such as diabetes mellitus

- Medications that could affect gastrointestinal movement within one week

- Implanted with a medical electronic device

- Active inflammatory bowel disease, toxic megacolon, toxic colitis

- Severe pulmonary, cardiac, renal, or hepatic disease

- Uncontrolled hypertension (systolic blood pressure>170 mm Hg, diastolic blood pressure>100 mm Hg);

- Disturbance of electrolytes

- Pregnancy or lactation

- Patients inability to provide written voluntary informed consent

- Participation in another clinical study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
polyethylene glycol

Device:
capsule endoscopy


Locations

Country Name City State
China Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Diseases, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai
China Huashan Hospital Shanghai Shanghai
China Tongren Hospital Affiliated to Shanghai Jiaotong University, China Shanghai Shanghai

Sponsors (4)

Lead Sponsor Collaborator
Zhizheng Ge Huashan Hospital, Shanghai East Hospital, Shanghai Tong Ren Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the quality of visualization of the small bowel The image quality was evaluated only in cases in which the capsule reached the cecum within the examination period. All CE images will be assessed at low speed (10 frames/s) under the AutoView mode of the RAPID workstation (Given Imaging). The intestinal mucosa is defined as clean if, less than 25% of the mucosal surface was covered by dark liquid, bubbles or debris. Using a timer, the investigators record the exact time period during which the small intestinal mucosa was clean. The definition of "excellent" is at least 90% of the overall small bowel mucosa is clean (the sum of "clean" time /total small bowel transit time>90%). And the definition of "good" is at least 80% of the overall small bowel mucosa is clean. We considered that "excellent" or "good" preparation is adequate to make an accurate diagnosis. one week after CE procedure
Secondary patient acceptability A visual analogical scale (VAS) is used to evaluate the degree of patients' discomfort. The numerical scale between 0 and 10, with 0 being no burden at all and 10 indicating an intolerable procedure.
The questionnaire provide information about whether they experienced nausea, bloating, or any discomfort during the bowel preparation, difficulty to complete the preparation, their willingness to repeat the same preparation in the future (yes or no)and did it affect their daily activity and nocturnal rest.
day of CE procedure
Secondary diagnostic rate one year
See also
  Status Clinical Trial Phase
Completed NCT05086471 - Performance Evaluation of the NaviCam SB Capsule Endoscope System for the Diagnosis of Small Bowel Diseases N/A
Completed NCT05548140 - Novel Motorized Spiral Enteroscopy Vs Single Balloon Enteroscopy In Patients With Small Bowel Disorders- A RCT N/A
Completed NCT03955081 - A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy
Recruiting NCT03321669 - Impact of Diet on Capsule Endoscopy N/A
Completed NCT04186390 - Learning Small Bowel Capsule Endoscopy
Recruiting NCT04152239 - Utility of Motorized Spiral Enteroscopy for Suspected Small Bowel Pathology
Completed NCT01088646 - Evaluation of PillCam® Express Capsule Endoscopy Delivery System N/A
Not yet recruiting NCT05522101 - Mini-sized MCE for Detection of Small Bowel in Children Under the Age of 10 Years N/A
Completed NCT05182983 - Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
Completed NCT04884113 - PowerSpiral Enteroscopy Performance and Safety
Recruiting NCT04959994 - Small Bowel Evaluation Using Novel Motorized Spiral Enteroscopy
Completed NCT03482661 - Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate N/A
Not yet recruiting NCT05408910 - Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis Phase 2/Phase 3
Recruiting NCT05004207 - Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.
Recruiting NCT00275184 - Bowel Preparation and Prokinetics in Capsule Endoscopy Phase 3
Recruiting NCT06111131 - Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures N/A
Completed NCT05228379 - Small Bowel Capsule Endoscopy: Experience From a Single Large Tertiary Care Centre
Not yet recruiting NCT03438695 - Total Motorized Spiral Enteroscopy Trial N/A
Suspended NCT03990207 - The PowerSpiral Antegrade Investigational Device Exemption (IDE) Study N/A
Recruiting NCT03962283 - Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users Phase 2/Phase 3